4.7 Review

Protein-Engineered Biomaterials for Cancer Theranostics

Journal

ADVANCED HEALTHCARE MATERIALS
Volume 7, Issue 20, Pages -

Publisher

WILEY
DOI: 10.1002/adhm.201800913

Keywords

angiogenesis; cancer stem cells; carbon nanomaterials

Funding

  1. National Research Programs from Ministry of Science and Technology (MOST) of China [2016YFA0201200]
  2. National Natural Science Foundation of China [51525203, 51761145041]
  3. Collaborative Innovation Center of Suzhou Nano Science and Technology
  4. Open Project of Jiangsu Key Laboratory for Carbon Based Functional Materials Devices
  5. Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions

Ask authors/readers for more resources

Proteins are an important class of biomaterials promising a variety of applications such as drug delivery, and imaging or therapy, owing to their biodegradability, biocompatibility, as well as inherent biological activities acting as enzymes, recognizing molecules, or therapeutics by themselves. Over the few past decades, different types of proteins with desired properties have been widely explored for biomedical applications. Many therapeutic proteins have now entered clinical use. This review therefore summarizes various strategies in the engineering of biomaterials for delivery of therapeutic proteins, as well as the recent development of protein-based biomaterials for cancer theranostics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available